All Pathways
DermatologyEmergency

Purpura Fulminans Emergency Management

Purpura Fulminans Emergency Management: Suspected Purpura Fulminans → LIFE-THREATENING EMERGENCY → Clinical Presentation → Classify Type of Purpura Fulm...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Suspected Purpura Fulminans

    Acute purpuric rash with progression to skin necrosis

    1. Warning

      LIFE-THREATENING EMERGENCY

      Mortality 40-50%, requires immediate intervention

      • Microvascular thrombosis → tissue necrosis
      • Associated with DIC
      • Progression from erythema → purpura → necrosis
      • Multi-organ failure common
      • ICU admission mandatory
      1. Action

        Clinical Presentation

        Characteristic progression

        • Initial: Erythematous macules
        • Evolution: Blue-black hemorrhagic purpura
        • Progression: Vesicles, bullae, hard eschars
        • Pain initially, then sensory loss
        • Fever, hypotension, hemorrhage elsewhere
        • End-organ damage (renal, pulmonary)
        1. Decision

          Classify Type of Purpura Fulminans

          Three distinct forms with different triggers

          1. Action

            Neonatal Form

            Hereditary protein C/S deficiency

            • Onset: Within 5 days of birth
            • Incidence: 1 per million live births
            • Cause: Severe protein C, S, or antithrombin III deficiency
            • Systemic thrombosis
            • Screen family members
            1. Action

              Immediate Resuscitation

              ABC stabilization and sepsis management

              • IV access, aggressive fluid resuscitation
              • Vasopressors if needed
              • Broad-spectrum antibiotics STAT
              • Blood cultures before antibiotics if possible
              • Airway management as needed
              1. Action

                Antibiotic Therapy (Infectious Form)

                Empiric coverage for likely pathogens

                • Carbapenem (meropenem) + Vancomycin
                • OR Ceftriaxone + Vancomycin
                • ADD Clindamycin for toxin inhibition
                • Adjust based on cultures
                • Duration: Complete course for source
                1. Action

                  Laboratory Monitoring

                  Serial coagulation and organ function

                  • PT/PTT, fibrinogen, D-dimer (DIC panel)
                  • Platelet count
                  • Protein C, Protein S, Antithrombin III levels
                  • Lactate, organ function panels
                  • Blood cultures, wound cultures
                  • CBC with differential
                  1. Action

                    Additional Therapies

                    Consider based on severity and response

                    • IVIG 1g/kg/day x 2 days (immunomodulation)
                    • Activated Protein C (drotrecogin alfa) - if available
                    • Corticosteroids for adrenal insufficiency
                    • Plasmapheresis (post-infectious form)
                    • Hyperbaric oxygen (limited evidence)
                    1. Warning

                      Surgical Management

                      Often required for survival

                      • Early surgical consultation
                      • Fasciotomy for compartment syndrome
                      • Debridement of necrotic tissue
                      • May require amputation of extremities
                      • Skin grafting in recovery phase
                      • Timing based on patient stability
                      1. Outcome

                        Survival

                        Significant morbidity expected

                        • Major amputations common
                        • Skin grafting required
                        • Long-term rehabilitation
                        • Genetic counseling (hereditary forms)
                        • Lifelong anticoagulation may be needed
                      2. Warning

                        Death

                        Mortality 40-50%

                        • Multi-organ failure
                        • Refractory septic shock
                        • Hemorrhage
                        • Early palliative care discussion appropriate
              2. Action

                DIC and Coagulation Management

                Restore coagulation balance

                • Fresh frozen plasma (FFP) for clotting factors
                • Platelet transfusion if <50,000 or bleeding
                • Cryoprecipitate if fibrinogen <100 mg/dL
                • Protein C concentrate if available (neonatal form)
                • Antithrombin III replacement if deficient
                • Heparin controversial - consider if thrombosis dominant
          2. Action

            Idiopathic (Post-Infectious)

            Acquired protein S deficiency

            • Onset: 7-10 days after infection
            • Preceding: Varicella, scarlet fever most common
            • Mechanism: Anti-protein S antibodies develop
            • Transient deficiency
            • Rarest form
          3. Warning

            Acute Infectious Form

            Most common - occurs during acute sepsis

            • 10-20% of meningococcal septicemia
            • Pathogens: N. meningitidis, S. pneumoniae, GAS
            • Endotoxin → DIC → protein C consumption
            • Higher risk in asplenia
            • Most severe form

Guideline Source

StatPearls: Purpura Fulminans

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Requires ICU-level care and multidisciplinary management
  • Protein C concentrate availability varies by institution
  • DIC management is complex and evolving
  • Surgical intervention often required
  • High morbidity including amputations even with survival

Applicable Regions

USEU
Version 1Next review: 2027-01-11

Frequently Asked Questions

What is the Purpura Fulminans Emergency Management?

The Purpura Fulminans Emergency Management is a emergency clinical algorithm for Dermatology. It provides a structured decision tree to guide clinical decision-making, based on StatPearls: Purpura Fulminans.

What guideline is the Purpura Fulminans Emergency Management based on?

This algorithm is based on StatPearls: Purpura Fulminans.

What are the limitations of the Purpura Fulminans Emergency Management?

Known limitations include: Requires ICU-level care and multidisciplinary management; Protein C concentrate availability varies by institution; DIC management is complex and evolving; Surgical intervention often required; High morbidity including amputations even with survival. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Purpura Fulminans Emergency Management appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free